Interestingly, NOD2’s role in cancer appears context-dependent, as evidenced by reports showing that NOD2 can inhibit tumorigenesis and enhance therapeutic efficacy through the AMPK pathway in hepatocellular cancer [7]. This evidence concerns the gene NOD2 and hepatocellular carcinoma.